research Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.
Search
forResearch
5 / 327 results
research Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.
research Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.
research Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.
research Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.
Community Join
3 / 1000+ resultscommunity Trial for TDM-105795 update from research office
The trial for TDM-105795 has been completed, and it was in phase 2A. The discussion seeks input on the next phases, 2B or 3, based on safety and efficacy.
community Pelage have presented only phase 2a. The rest of phase 2 for PP405 will be presented at a later medical meeting
PP405's phase 2a trial results were presented, focusing on safety and pharmacokinetics, with a future meeting planned to share the full dataset. The trial includes a randomized controlled portion and an open-label extension, with no indication of phase 2B completion.
community Are we still getting the PP405 phase 2a results by the end of March?
People are discussing the anticipated release of PP405 phase 2a results, expected by the end of March, with some skepticism about its effectiveness. There is cautious optimism due to past experiences with similar treatments like Breezula, despite concerns about the lack of presentation at the AAD 2026 conference.
Clinics
6 / 15 results- 9
TrichologyOoo "Gruppa Kompaniy "Trilodzhik"Tekstil’shchiki · RU - 23Hair Loss TreatmentsCentre Du Triangle D'or Laser And Aesthetic Medicine Le MansLe Mans · FR
- 49
SMPTrillium InkEverett, WA · US - 13
TrichologyHair Loss TreatmentsTrilabitRome · IT - 53
Hair Loss TreatmentsTriangle Wellness and Anti-AgingRaleigh, NC · US - 80
Hair Loss TreatmentsTrichologyTriangle TrichologyRaleigh, NC · US
Experts
6 / 10 results- 76
Hair Loss SpecialistAdrián Alegre
Madrid, Madrid, Spain
- 90
Hair Transplant SurgeonDr. Ilker Apaydin, MD
Istanbul, Türkiye
- 92
Hair Transplant SurgeonDr. Wilker Juliani, MD
Rio de Janeiro, RJ, Brazil
- 62
Hair Transplant SurgeonOp. Dr. İlker Çiçek, MD
Esenler, Türkiye
- 72
TrichologistTracey Walker FIT
Peterborough, United Kingdom
- 60
SMP SpecialistDion Walker
Farmington Hills, United States
Learn
— no results